John J. Ashley
About
In The Last Decade
John J. Ashley
23 papers receiving 720 citations
Peers
Comparison fields: 5 of 114
- Pediatrics, Perinatology and Child Health 216
- Pharmacology 141
- Pulmonary and Respiratory Medicine 122
- Oncology 107
- Molecular Biology 106
Countries citing papers authored by John J. Ashley
This map shows the geographic impact of John J. Ashley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Ashley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Ashley more than expected).
Fields of papers citing papers by John J. Ashley
This network shows the impact of papers produced by John J. Ashley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Ashley. The network helps show where John J. Ashley may publish in the future.
Co-authorship network of co-authors of John J. Ashley
This figure shows the co-authorship network connecting the top 25 collaborators of John J. Ashley. A scholar is included among the top collaborators of John J. Ashley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Ashley. John J. Ashley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | Cyclosporine Plasma Unbound Fraction in Heart and Lung Transplantation Recipients | Therapeutic Drug Monitoring | Fatemeh Akhlaghi, John J. Ashley et al. | 23 |
| 2 | Indirect Estimation of the Unbound Fraction of Cyclosporine in Plasma | Therapeutic Drug Monitoring | Fatemeh Akhlaghi, John J. Ashley et al. | 5 |
| 3 | Synthesis of a Fluorescent Derivative of Cyclosporin A for High-Performance Liquid Chromatography Analysis | Journal of Pharmaceutical Sciences | Romano A. Fois, John J. Ashley | 13 |
| 4 | Curve-fitting in pharmacokinetics ? A comparison between gamma-and biexponential fits | European Journal of Clinical Pharmacology | Emma Sainsbury, John J. Ashley | 13 |
| 5 | Pharmacokinetics and plasma-concentration-effect relationships of prenalterol in cardiac failure | European Journal of Clinical Pharmacology | Emma Sainsbury, D. A. Fitzpatrick et al. | 6 |
| 6 | Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure. | Heart | Philip J. Currie, Michael Kelly et al. | 19 |
| 7 | Pharmacokinetics of betamethasone in healthy adults after intravenous administration | European Journal of Clinical Pharmacology | M. C. Petersen, Roger L. Nation et al. | 39 |
| 8 | Disposition of betamethasone in parturient women after intravenous administration | European Journal of Clinical Pharmacology | M. C. Petersen, C.B. Collier et al. | 29 |
| 9 | Verapamil kinetics in normal subjects and patients with coronary artery spasm | Clinical Pharmacology & Therapeutics | Ben Freedman, David Richmond et al. | 103 |
| 10 | Disposition of synthetic glucocorticoids: II. Dexamethasone in parturient women | Clinical Pharmacology & Therapeutics | M. C. Petersen, John J. Ashley et al. | 38 |
| 11 | The placental transfer of betamethasone | European Journal of Clinical Pharmacology | M. C. Petersen, Roger L. Nation et al. | 40 |
| 12 | Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults | Journal of Pharmacokinetics and Biopharmaceutics | R. G. Moore, John J. Ashley et al. | 93 |
| 13 | Quantitation of dexamethasone in biological fluids using high-performance liquid chromatography | Journal of Chromatography B Biomedical Sciences and Applications | John J. Ashley, R. G. Moore et al. | 42 |
| 14 | Oral Administration of Erythromycin Stearate: Effect of Dosage form on Plasma Levels | The Medical Journal of Australia | E. J. Triggs, John J. Ashley | 4 |
| 15 | Pharmacokinetics in the elderly | European Journal of Clinical Pharmacology | E. J. Triggs, Roger L. Nation et al. | 119 |
| 16 | Kinetics of diphenylhydantoin elimination in rats | Journal of Pharmacokinetics and Biopharmaceutics | John J. Ashley, Gerhard Levy | 38 |
| 17 | Effect of product inhibition on kinetics of drug elimination | Journal of Pharmacokinetics and Biopharmaceutics | Donald Perrier, John J. Ashley et al. | 46 |
| 18 | Effect of an Inhibitor of Glucuronide Formation on Elimination Kinetics of Diphenylhydantoin in Rats | Journal of Pharmaceutical Sciences | Gerhard Levy, John J. Ashley | 22 |
| 19 | Effect of Vehicle Viscosity and an Anticholinergic Agent on Bioavailability of a Poorly Absorbed Drug (Phenolsulfonphthalein) in Man | Journal of Pharmaceutical Sciences | John J. Ashley, Gerhard Levy | 11 |
| 20 | THE METABOLITES OF CARDIAC GLYCOSIDES IN HUMAN URINE | Journal of Biological Chemistry | John J. Ashley, Bradley T. Brown et al. | 41 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.